CClinicalTrials.gg
CompletedNCT02705586vMBSRUpdated Oct 31, 2019Results posted

Video Based Mindfulness Based Stress Reduction

An interventional study of Mindfulness in Parkinson's Disease, sponsored by Oregon Health and Science University. Completed at 2 sites in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-31.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

To evaluate the feasibility of a video based mindfulness intervention for stress reduction and to evaluate the cortisol response in persons with PD and their caregivers. The data from this project will be used for a future grant application of a stress reduction intervention in persons with PD.

Read the detailed description

Participants will be enrolled at the VA Portland and have a baseline assessment. The baseline will assess neurological disorders (including Parkinsonism) and current stress. All participants will attend 10 weeks of mindfulness based stress reduction (MBSR) through video feed on the Portland VA campus. During the week prior to the first class and the week after the last class, participants will complete questionnaires regarding stress, collect saliva samples, and, for the Parkinson's patient, monitor motor symptoms of PD using diaries and inertial sensors. A final visit will assess stress, neurological diseases, and Parkinsonism.

02

Conditions studied

  • Parkinson's Disease

Browse trials for

Keywords

  • Movement disorders
  • Metabolic Stress
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 13 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Parkinson's disease
  • Some Postural instability
  • Tremor in upper limb
  • Caregiver willing to also participate

Exclusion criteria

Exclusion Criteria:

  • No neurological disease
  • Cognitive deficits
  • Other neurological/psychological disorder
  • Completion of a stress reduction program in the last 12 months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    only one arm - open label study

    2 hour video based mindfulness-based stress reduction class once a week for 10 weeks.

    Behavioral: Mindfulness

Interventions

  • BehavioralMindfulness

    Mindfulness focuses on helping participants understand their personal reactions to stress, teaches skills that provide means to modify stress reactions, and promotes self-care and feelings of competence and mastery. In addition to weekly class sessions, participants are asked to do an hour of home practice the days that the class does not meet.

    Also known as: Mindfulness Based Stress REduction

06

What researchers measure

Primary outcomes

  1. Salivary Cortisol Levels (Pre- and Post-) Mindfulness-Based Stress Reduction Program

    Enzyme-linked immunoassay salivary cortisol levels (ng/mL) taken prior to Mindfulness-Based Stress Reduction will be compared to samples taken after the intervention.

    Time frame: Baseline to 12 weeks

07

Results

Posted Oct 31, 2019

Participant flow

From March 2016 to May 2016, 8 Parkinson's disease veterans and their caregivers were recruited for the 10-week Mindfulness-Based Stress Reduction classes held at the VA Portland Health Care System in Portland, Oregon.

Participant flow — Overall Study
MilestoneOnly One Arm - Open Label Study
Started13
Completed5
Not completed8
Withdrew: Health issues2
Withdrew: Transportation difficulties5
Withdrew: Vacation/planned absence1

Outcome measures

PrimarySalivary Cortisol Levels (Pre- and Post-) Mindfulness-Based Stress Reduction Program

Enzyme-linked immunoassay salivary cortisol levels (ng/mL) taken prior to Mindfulness-Based Stress Reduction will be compared to samples taken after the intervention.

Time frame:
Baseline to 12 weeks
Reported as:
Mean · Concentration (ng/mL)
Salivary Cortisol Levels (Pre- and Post-) Mindfulness-Based Stress Reduction Program
Concentration (ng/mL)Only One Arm - Open Label Study
Salivary Cortisol Levels (Pre- and Post-) Mindfulness-Based Stress Reduction Program-33.1 ± 41.5

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Only One Arm - Open Label Study—0/9 (0%)0/9 (0%)

Baseline characteristics

Baseline visits completed on 13 participants; Parkinson's disease and caregivers. 4 individuals dropped out prior to class week 1 due to difficulty travelling to the VA/too busy to come to the VA weekly. Analysis on 13 (individuals - both Parkinson's disease and caregivers).

Age, Continuous
Age, Continuous(years)Only One Arm - Open Label Study
Mean71.7 ± 6.8
Sex: Female, Male
Sex: Female, Male(Participants)Only One Arm - Open Label Study
Female6
Male7
Region of Enrollment
Region of Enrollment(Participants)Only One Arm - Open Label Study
United States13
Years of Formal Education
Years of Formal Education(years)Only One Arm - Open Label Study
Mean14.9 ± 2.5
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA)(units on a scale)Only One Arm - Open Label Study
Mean25.4 ± 2.2
United Parkinsons Disease Rating Scale - Part III motor section (UPDRS)
United Parkinsons Disease Rating Scale - Part III motor section (UPDRS)(units on a scale)Only One Arm - Open Label Study
Mean26.6 ± 8.5
Hoehn & Yahr
Hoehn & Yahr(units on a scale)Only One Arm - Open Label Study
Mean2.2 ± 0.3
Perceived Stress Scale (PSS)
Perceived Stress Scale (PSS)(units on a scale)Only One Arm - Open Label Study
Mean12.7 ± 7.5

4 further baseline measures are reported on the registry.

08

Study locations

2 sites
  • Oregon Health & Science University
    Portland, Oregon 97239, United States
  • VA Portland Health Care System
    Portland, Oregon 97239, United States
09

References and documents

Publications

  • Armento ME, Stanley MA, Marsh L, Kunik ME, York MK, Bush AL, Calleo JS. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012;2(2):135-51. doi: 10.3233/JPD-2012-12080. PubMed 23939438 ↗
  • Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR; International Parkinson and Movement Disorder Society Telemedicine Task Force. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014 Jun;29(7):871-83. doi: 10.1002/mds.25903. Epub 2014 May 17. PubMed 24838316 ↗
  • Almeida DM, Wethington E, Kessler RC. The daily inventory of stressful events: an interview-based approach for measuring daily stressors. Assessment. 2002 Mar;9(1):41-55. doi: 10.1177/1073191102091006. PubMed 11911234 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02705586
Lead sponsor
Oregon Health and Science University
Collaborators
Portland VA Medical Center
Responsible party
Amie Hiller, MD (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
Mar 10, 2016
Start date
Mar 2016
Primary completion
Jul 2016
Completion
Jul 2016
Results posted
Oct 31, 2019
Last update
Oct 31, 2019

Study contacts

Amie L Hiller (Peterson), MD
principal investigator · VA Porltand Health Care system

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion